AllScience & ResearchPractical TipsPatient VoiceEconomic Impact

Economic Impact & Company News

Virta Convenes Industry Leaders and Patients to Discuss the Future of Chronic Disease Care, Health Equity, Drug Pricing, and More

U-Haul Team Members Enrolled with Virta Health Eliminate Over One-Third of Diabetes Medications in Just 90 Days

Diabetes Reversal Leader Virta Health Receives Recognition for Delivering Best-In-Class Cost Savings and Health Outcomes

Virta Recognized for Best-In-Class Outcomes and Savings

Diabetes Reversal Leader Virta Health Showcases Transformative, Long-Lasting Cardiometabolic Health Improvements for Veteran Patients

New Evidence for Long-term Type 2 Diabetes Reversal in Clinical Trial and Real World Settings

Virta Health Highlights Lasting, Transformative Health Improvements In 5-Year Diabetes Reversal Study

Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer

Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings

Virta Health Reveals Triple-Digit Growth With Health Plans Amid Industry Shift Towards Diabetes Reversal

Diabetes Reversal Leader Virta Health Appoints New Executives to Leadership Team and Board of Directors

Virta Health’s Diabetes Reversal Treatment Drives Savings of More Than $10k Per Patient Over Two Years, New Analysis Shows

What’s the Next Big Breakthrough in Healthcare? Virta Convenes 20+ Industry Leaders to Explore Bold Solutions to Our Most Daunting Challenges

Diabetes Reversal Leader Virta Health Demonstrates Promising Results on Mitigating COVID-19 Severity for People with Type 2 Diabetes

Diabetes Reversal Leader Virta Health Appoints Public Policy Veteran Cybele Bjorklund to Lead Government Efforts

Mashantucket Pequot Tribal Nation’s Partnership with Virta Health Shows Unprecedented Progress In Reversing the Community’s Type 2 Diabetes Epidemic

Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

Virta Health’s Reversal Treatment Prevents Progression to Type 2 Diabetes in 97% of Prediabetes Patients, New Research Shows

Using Virta’s Reversal Treatment To Help The 88 Million Americans With Prediabetes

Diabetes Reversal Leader Virta Health Appoints Chief Financial Officer

Virta Health Raises $65 Million Series D to Scale Type 2 Diabetes Reversal Treatments

This Veteran’s Day, Virta Honors a Very Special Request from One Retiring US Navy Officer

Virta Health Adds Prediabetes Reversal, Obesity Treatment, and Provider-Led Diabetes Management to Clinical Services

Expanding chronic disease reversal beyond type 2 diabetes

Virta Health Launches Beyond Telemedicine Conference, Convening 40+ Industry Leaders to Discuss Today’s Most Pressing Issues in Telehealth

Virta Health Partners With St. Louis Area Business Health Coalition to Expand Access to Type 2 Diabetes Reversal Treatment

Why We're Hopeful for the Future of Diabetes Care: Looking Back at the Past 5 Years at Virta Health

Virta Health Receives EHIR Traction Award for Spring 2020

Why I am Joining Virta Health After 40 Years in Diabetes Care

Virta Health Appoints Dr. Robert Ratner, Former Chief Scientific and Medical Officer of the American Diabetes Association, as Chief Medical Officer

Virta Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

Validating the outcomes of the Virta Treatment

Virta is rebuilding diabetes care from the ground up—here's why it's better for patients and providers

Virta Health Raises $93 Million to Combat the $400B Type 2 Diabetes Epidemic and Expand Diabetes Reversal to Millions

Why U.S. Veterans Have us Excited for the Future of Type 2 Diabetes Care

Veterans Living with Type 2 Diabetes Achieve Rapid Health Improvements in Virta Health Partnership with VA

Virta Health Partners with Accolade to Expand Access to Type 2 Diabetes Reversal Treatment

Virta Health’s Type 2 Diabetes Reversal Treatment Now Available to Blue Shield of California Members

Virta Health Engages with Willis Towers Watson to Accelerate Adoption of Type 2 Diabetes Reversal Treatment

New Virta Health Results Show Sustained Type 2 Diabetes Reversal at Two Years and Continued Reduction of Insulin

New Virta research: sustainable diabetes reversal results lasting 2 years

Virta Health Partners with U.S. Department of Veterans Affairs to Help Veterans with Type 2 Diabetes

Reversing Type 2 Diabetes with Bariatric Surgery, Very Low Calorie Diets, and Carbohydrate Restriction: A Review of the Evidence

4 Reasons the Virta Treatment Achieves a 90% Patient Retention Rate at One Year

Digital Health Veteran Derek Newell and Organizational Behavior Expert Lucia Guillory Join Virta Health

Virta's impact on NAFLD, the $100B problem affecting 60% of people with T2D

Virta Health Trial Demonstrates Improvement in Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis

New Virta Health Results Add Improved Sleep as Benefit of the Virta Treatment

Survey says: the standard of type 2 diabetes care falls short for both patients and providers

Putting Our Money Where Our Medicine is: Reversing Diabetes with 100% of Fees at Risk

Virta Health Puts 100% of Fees at Risk with Announcement of New Pricing Structure

Finding Hope During National Diabetes Awareness Month

How Machine Learning Enhances the Virta Treatment

Virta Health Continues Rapid Growth with New Executives, New Customers, and Industry Validation for the Virta Treatment

Reflecting on 3 Years of Reversing Type 2 Diabetes at Virta Health

How to evaluate clinical outcomes: Three questions employers should ask vendors

Future Virta Research with Amy McKenzie, PhD, Senior Research Scientist

Motivation and Behavior Change: Why Tracking Isn’t Always Effective For Diabetes Treatment

Reversing the Trend of Diabetes Pharmaceutical Spending with the Virta Treatment

Virta Health Aiming to Eradicate Type 2 Diabetes in Indiana with Announcement of New Commercial Partnerships

Virta's Quest to Eliminate Type 2 Diabetes in Indiana

Improving Cardiovascular Disease Risk Factors with the Virta Treatment

Virta Health Changing Status Quo in Chronic Disease Care with Strong Cardiovascular Outcomes from Type 2 Diabetes Reversal Study

Virta Health Raises $45 Million to Expand Treatment for Type 2 Diabetes Reversal

With $45 million of new capital, Virta is ready to accelerate its growth

Type 2 Diabetes Reversal at Scale—What is Behind the Virta Treatment?

The Economic Benefits of Type 2 Diabetes Reversal

Virta Health’s Treatment for Sustained Type 2 Diabetes Reversal Provides New Hope for Chronic Disease Patients

With Sustained Type 2 Diabetes Reversal, Management is Becoming a Thing of the Past

One Year Clinical Trial Outcomes Provide Evidence for Changing the Way We Care for Patients with Type 2 Diabetes

Why Continuous Remote Telemedicine is the Future of Medicine

The Twenty Minute VC—An Interview with Sami Inkinen

Machine Learning in Healthcare

How Much Money Could Your State Save with Diabetes Reversal?

Former CMS Head Dr. Don Berwick Joins Virta Health Board of Directors

National Spending on Privately Insured People with Diabetes Continues to Climb

From Initial Success to Sustainability in Diabetes Reversal—a Snapshot of Six Month Outcomes

Boilermakers, Difference Makers

Purdue, Virta Health Partner In New Approach To Treat Type 2 Diabetes

Death, Taxes, and Diabetes Progression? One of These is Not Like the Others.

We are on a Mission to Reverse Type 2 Diabetes in 100 Million People

Virta Health Launches to Reverse Type 2 Diabetes as New Study Demonstrates Reversal Possible Without Surgery

The Science of Diabetes Reversal—Virta Clinical Results

We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.

Continue